Takeda approval ushers in new wave of sleep drugs
An FDA nod mostly clears the way for Orzeyful to enter, by Wall Street estimates, a multibillion-dollar market for drugs that boost “orexin” proteins.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.




